Safotibant

CAS No. 633698-99-4

Safotibant( —— )

Catalog No. M34704 CAS No. 633698-99-4

Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 222 Get Quote
5MG 333 Get Quote
10MG 504 Get Quote
25MG 790 Get Quote
50MG 1086 Get Quote
100MG 1431 Get Quote
500MG 2871 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Safotibant
  • Note
    Research use only, not for human use.
  • Brief Description
    Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
  • Description
    Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Bradykinin Receptor
  • Recptor
    Bradykinin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    633698-99-4
  • Formula Weight
    502.63
  • Molecular Formula
    C25H34N4O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(N(CCOCC(N(CC1=CC=C(C=C1)C=2NCCN2)C)=O)C)(=O)(=O)C3=C(C)C=C(OC)C=C3C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • [Des-Arg9]-Bradykini...

    [Des-Arg9]-Bradykinin is a Bradykinin (B1) receptor agonist that displays selectivity for B1 over B2 receptors.

  • Bradykinin (2-9)

    Bradykinin (2-9) is a metabolite of Bradykinin, cleaved by Aminopeptidase P. Bradykinin (2-9) is an amino-truncated Bradykinin peptide.

  • 5-Hydroxy-1-methylhy...

    NZ-419 is an antioxidant potentially for the treatment of renal failure.